Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL8375149

CN(C)C(=O)O.Nc1ccncc1O.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 7/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4C Q9H3R0 2/20 0.42
MEN1 O00255 1/20 0.42
KDM6B O15054 1/20 0.42
KDM4A O75164 1/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4D Q6B0I6 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
P2RX1 P51575 1/20 0.37
GPBAR1 Q8TDU6 2/20 0.36
EP300 Q09472 1/20 0.35
KAT2B Q92831 1/20 0.35
KAT8 Q9H7Z6 1/20 0.35
SLC22A12 Q96S37 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylcarbate SCHEMBL8375856 0.91 KDM4C (0.50) L3MBTL1KDM4EALDH1A1KDM4CMEN1
Trifluoroacetic Acid SCHEMBL8375150 0.76 KDM4E (0.39) L3MBTL1KDM4EALDH1A1KDM4CMEN1
SCHEMBL8375129 0.76 KDM4E (0.45) L3MBTL1KDM4EALDH1A1KDM4CMEN1
SCHEMBL218758 0.75
SCHEMBL30015578 0.75
Methane SCHEMBL15389723 0.73
Hydrochloric Acid SCHEMBL31519177 0.73
Trifluoroacetic Acid SCHEMBL6595462 0.72 AOC1 (0.44) L3MBTL1KDM4EALDH1A1KDM4CMEN1
Trifluoroacetic Acid SCHEMBL29952721 0.71 L3MBTL1 (0.42) L3MBTL1KDM4EALDH1A1KDM4CMEN1
SCHEMBL2645085 0.71 KDM5A (0.44) L3MBTL1KDM4EALDH1A1KDM4CMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US claimed
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed
EP-0477903-A2 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-04-01 EP disclosed